Annual Operating Profit
-$61.10 M
-$1.46 M-2.44%
December 31, 2023
Summary
- As of February 7, 2025, MIST annual operating income is -$61.10 million, with the most recent change of -$1.46 million (-2.44%) on December 31, 2023.
- During the last 3 years, MIST annual operating profit has fallen by -$10.39 million (-20.49%).
- MIST annual operating profit is now -638.97% below its all-time high of -$8.27 million, reached on December 31, 2017.
Performance
MIST Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Operating Profit
-$9.62 M
+$46.00 K+0.48%
September 30, 2024
Summary
- As of February 7, 2025, MIST quarterly operating income is -$9.62 million, with the most recent change of +$46.00 thousand (+0.48%) on September 30, 2024.
- Over the past year, MIST quarterly operating profit has increased by +$5.74 million (+37.40%).
- MIST quarterly operating profit is now -1450.56% below its all-time high of $712.00 thousand, reached on June 30, 2021.
Performance
MIST Quarterly Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM Operating Profit
-$43.55 M
+$5.74 M+11.65%
September 30, 2024
Summary
- As of February 7, 2025, MIST TTM operating income is -$43.55 million, with the most recent change of +$5.74 million (+11.65%) on September 30, 2024.
- Over the past year, MIST TTM operating profit has increased by +$17.50 million (+28.67%).
- MIST TTM operating profit is now -923.60% below its all-time high of -$4.25 million, reached on March 31, 2018.
Performance
MIST TTM Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Operating Profit Formula
Operating Profit = Gross Profit − Operating Expenses
MIST Operating Profit Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -2.4% | +37.4% | +28.7% |
| 3 y3 years | -20.5% | +38.0% | +28.7% |
| 5 y5 years | -156.5% | +38.0% | +28.7% |
MIST Operating Profit Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -41.9% | at low | at high | +43.2% | -1.1% | +30.6% |
| 5 y | 5-year | -41.9% | at low | -1450.6% | +49.1% | -33.1% | +31.6% |
| alltime | all time | -639.0% | at low | -1450.6% | +49.1% | -923.6% | +31.6% |
Milestone Pharmaceuticals Operating Profit History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$9.62 M(-0.5%) | -$43.55 M(-11.7%) |
| Jun 2024 | - | -$9.66 M(-7.8%) | -$49.30 M(-12.1%) |
| Mar 2024 | - | -$10.48 M(-24.1%) | -$56.07 M(-8.2%) |
| Dec 2023 | -$61.10 M(+2.4%) | -$13.80 M(-10.2%) | -$61.10 M(+0.1%) |
| Sep 2023 | - | -$15.36 M(-6.5%) | -$61.06 M(+0.5%) |
| Jun 2023 | - | -$16.44 M(+6.0%) | -$60.73 M(-0.6%) |
| Mar 2023 | - | -$15.50 M(+12.7%) | -$61.10 M(+2.4%) |
| Dec 2022 | -$59.64 M(+38.5%) | -$13.76 M(-8.5%) | -$59.64 M(-5.0%) |
| Sep 2022 | - | -$15.03 M(-10.6%) | -$62.80 M(+1.2%) |
| Jun 2022 | - | -$16.81 M(+19.6%) | -$62.04 M(+39.3%) |
| Mar 2022 | - | -$14.05 M(-17.0%) | -$44.53 M(+3.4%) |
| Dec 2021 | -$43.07 M | -$16.92 M(+18.5%) | -$43.07 M(+23.4%) |
| Sep 2021 | - | -$14.27 M(-2104.6%) | -$34.92 M(+6.7%) |
| Jun 2021 | - | $712.00 K(-105.7%) | -$32.73 M(-29.7%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2021 | - | -$12.59 M(+43.7%) | -$46.55 M(-8.2%) |
| Dec 2020 | -$50.71 M(-12.4%) | -$8.76 M(-27.5%) | -$50.71 M(-16.7%) |
| Sep 2020 | - | -$12.09 M(-7.8%) | -$60.84 M(-2.6%) |
| Jun 2020 | - | -$13.11 M(-21.8%) | -$62.48 M(-1.9%) |
| Mar 2020 | - | -$16.76 M(-11.3%) | -$63.71 M(+10.1%) |
| Dec 2019 | -$57.88 M(+143.0%) | -$18.89 M(+37.6%) | -$57.88 M(+17.9%) |
| Sep 2019 | - | -$13.72 M(-4.2%) | -$49.10 M(+19.3%) |
| Jun 2019 | - | -$14.33 M(+31.1%) | -$41.16 M(+34.9%) |
| Mar 2019 | - | -$10.93 M(+8.1%) | -$30.50 M(+28.0%) |
| Dec 2018 | -$23.82 M(+188.1%) | -$10.11 M(+74.7%) | -$23.82 M(+73.7%) |
| Sep 2018 | - | -$5.79 M(+57.4%) | -$13.72 M(+72.9%) |
| Jun 2018 | - | -$3.68 M(-13.6%) | -$7.93 M(+86.4%) |
| Mar 2018 | - | -$4.25 M | -$4.25 M |
| Dec 2017 | -$8.27 M | - | - |
FAQ
- What is Milestone Pharmaceuticals annual operating income?
- What is the all time high annual operating profit for Milestone Pharmaceuticals?
- What is Milestone Pharmaceuticals annual operating profit year-on-year change?
- What is Milestone Pharmaceuticals quarterly operating income?
- What is the all time high quarterly operating profit for Milestone Pharmaceuticals?
- What is Milestone Pharmaceuticals quarterly operating profit year-on-year change?
- What is Milestone Pharmaceuticals TTM operating income?
- What is the all time high TTM operating profit for Milestone Pharmaceuticals?
- What is Milestone Pharmaceuticals TTM operating profit year-on-year change?
What is Milestone Pharmaceuticals annual operating income?
The current annual operating profit of MIST is -$61.10 M
What is the all time high annual operating profit for Milestone Pharmaceuticals?
Milestone Pharmaceuticals all-time high annual operating income is -$8.27 M
What is Milestone Pharmaceuticals annual operating profit year-on-year change?
Over the past year, MIST annual operating income has changed by -$1.46 M (-2.44%)
What is Milestone Pharmaceuticals quarterly operating income?
The current quarterly operating profit of MIST is -$9.62 M
What is the all time high quarterly operating profit for Milestone Pharmaceuticals?
Milestone Pharmaceuticals all-time high quarterly operating income is $712.00 K
What is Milestone Pharmaceuticals quarterly operating profit year-on-year change?
Over the past year, MIST quarterly operating income has changed by +$5.74 M (+37.40%)
What is Milestone Pharmaceuticals TTM operating income?
The current TTM operating profit of MIST is -$43.55 M
What is the all time high TTM operating profit for Milestone Pharmaceuticals?
Milestone Pharmaceuticals all-time high TTM operating income is -$4.25 M
What is Milestone Pharmaceuticals TTM operating profit year-on-year change?
Over the past year, MIST TTM operating income has changed by +$17.50 M (+28.67%)